Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. April 2013 12:00 ET | Quelle: Calypte Biomedical Corporation

Calypte Biomedical and Maxim Biomedical Announce Joint Distribution of Incidence Testing Assays

PORTLAND, Ore., April 25, 2013 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (OTCBB:CBMC) and Maxim Biomedical Inc. today announced a reciprocal distribution agreement under which customers may...
14. Oktober 2011 17:27 ET | Quelle: Calypte Biomedical Corporation

Calypte Biomedical Secures Funding to Conduct Clinical Trials

PORTLAND, Ore., Oct. 14, 2011 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (OTCBB:CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, today announced that it has entered into...
02. März 2011 18:57 ET | Quelle: Calypte Biomedical Corporation

Calypte Biomedical Announces Successful Conclusion of Internal Trials

PORTLAND, Ore., March 2, 2011 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (OTCBB:CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, today announced successful completion of...
08. November 2010 14:40 ET | Quelle: Calypte Biomedical Corporation

Calypte Biomedical Awarded Therapeutic Discovery Project Grant

PORTLAND, Ore., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (Pink Sheets:CBMC), the developer, manufacturer and marketer of the Aware™ HIV-1/2 OMT (oral fluid) HIV test,...